Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19 and multiple sclerosis: challenges and lessons for patient care.
Prosperini L, Arrambide G, Celius EG, Goletti D, Killestein J, Kos D, Lavorgna L, Louapre C, Sormani MP, Stastna D, Ziemssen T, Di Filippo M. Prosperini L, et al. Among authors: lavorgna l. Lancet Reg Health Eur. 2024 Aug 22;44:100979. doi: 10.1016/j.lanepe.2024.100979. eCollection 2024 Sep. Lancet Reg Health Eur. 2024. PMID: 39429966 Free PMC article. Review.
Signs and symptoms of COVID-19 in patients with multiple sclerosis.
Schiavetti I, Carmisciano L, Ponzano M, Cordioli C, Cocco E, Marfia GA, Inglese M, Filippi M, Radaelli M, Bergamaschi R, Immovilli P, Capobianco M, De Rossi N, Brichetto G, Scandellari C, Cavalla P, Pesci I, Confalonieri P, Perini P, Trojano M, Lanzillo R, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M, Sormani MP; MuSC-19 Study Group. Schiavetti I, et al. Eur J Neurol. 2022 Dec;29(12):3728-3736. doi: 10.1111/ene.15554. Epub 2022 Sep 23. Eur J Neurol. 2022. PMID: 36086905 Free PMC article.
Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis.
Abbadessa G, Ponzano M, Bile F, Miele G, Signori A, Cepparulo S, Sparaco M, Signoriello E, Maniscalco GT, Lanzillo R, Morra VB, Lus G, Sormani MP, Lavorgna L, Bonavita S. Abbadessa G, et al. Among authors: lavorgna l. Mult Scler Relat Disord. 2023 Jul;75:104731. doi: 10.1016/j.msard.2023.104731. Epub 2023 Apr 28. Mult Scler Relat Disord. 2023. PMID: 37163840
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop).
Schiavetti I, Signori A, Albanese A, Frau J, Cocco E, Lorefice L, di Lemme S, Fantozzi R, Centonze D, Landi D, Marfia G, Signoriello E, Lus G, Zecca C, Gobbi C, Iodice R, Malimpensa L, Cordioli C, Ferraro D, Ruscica F, Pasquali L, Repice A, Immovilli P, Ferrò MT, Bonavita S, Di Filippo M, Abbadessa G, Govone F, Sormani MP; CladStop study group. Schiavetti I, et al. Eur J Neurol. 2024 Jun;31(6):e16250. doi: 10.1111/ene.16250. Epub 2024 Mar 28. Eur J Neurol. 2024. PMID: 38549186 Free PMC article.
A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting.
Lanzillo R, Sparaco M, Lavorgna L, Carmisciano L, Signoriello E, Signori A, Costabile T, Maniscalco GT, Saccà F, Cepparulo S, Russo CV, Bisecco A, Frattaruolo N, Strianese A, Lus G, Brescia Morra V, Bonavita S. Lanzillo R, et al. Among authors: lavorgna l. Neurol Sci. 2020 Nov;41(11):3235-3241. doi: 10.1007/s10072-020-04367-9. Epub 2020 May 10. Neurol Sci. 2020. PMID: 32388646
COVID-19 pandemic and mental distress in multiple sclerosis: Implications for clinical management.
Costabile T, Carotenuto A, Lavorgna L, Borriello G, Moiola L, Inglese M, Petruzzo M, Trojsi F, Ianniello A, Nozzolillo A, Cellerino M, Boffa G, Rosa L, Servillo G, Moccia M, Bonavita S, Filippi M, Lanzillo R, Brescia Morra V, Petracca M. Costabile T, et al. Among authors: lavorgna l. Eur J Neurol. 2021 Oct;28(10):3375-3383. doi: 10.1111/ene.14580. Epub 2020 Nov 3. Eur J Neurol. 2021. PMID: 33043560 Free PMC article.
Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis.
Esposito S, Sparaco M, Maniscalco GT, Signoriello E, Lanzillo R, Russo C, Carmisciano L, Cepparulo S, Lavorgna L, Gallo A, Trojsi F, Brescia Morra V, Lus G, Tedeschi G, Saccà F, Signori A, Bonavita S. Esposito S, et al. Among authors: lavorgna l. Mult Scler Relat Disord. 2021 Jan;47:102636. doi: 10.1016/j.msard.2020.102636. Epub 2020 Nov 22. Mult Scler Relat Disord. 2021. PMID: 33333418
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study.
Miele G, Abbadessa G, Cavalla P, Valentino P, Marfia GA, Landi D, Bosa C, Vercellino M, De Martino A, Ponzano M, Lavorgna L, Bonavita S. Miele G, et al. Among authors: lavorgna l. Mult Scler Relat Disord. 2022 Dec;68:104395. doi: 10.1016/j.msard.2022.104395. Epub 2022 Nov 3. Mult Scler Relat Disord. 2022. PMID: 36544324
139 results